新华制药：子公司获得熊去氧胆酸胶囊药品注册证书

Core Viewpoint - The company announced that its wholly-owned subsidiary, Shandong Zibo Xinda Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the registration certificate of Ursodeoxycholic Acid Capsules, indicating a significant development in its product portfolio [1] Group 1: Product Details - Ursodeoxycholic Acid Capsules are classified as a Class 4 chemical drug with a specification of 250mg [1] - The drug is indicated for the treatment of cholesterol gallstones (specifically those that are X-ray penetrable and with normal gallbladder contraction function) [1] - It is also used for cholestatic liver diseases such as primary biliary cirrhosis and for bile reflux gastritis [1]